# Top 50 Biotechnology VC (Venture Capital) Funds in May 2026

## ARCH Venture Partners
- Type: VC Fund
- Location: Chicago, Illinois, United States
- Relevant deals: 112
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Therapeutics

ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences

## OrbiMed
- Type: VC Fund
- Location: New York, New York, United States
- Relevant deals: 95
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Pharmaceutical

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

## Sofinnova Partners
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 84
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

## Alexandria Venture Investments
- Type: VC Fund
- Location: Pasadena, California, United States
- Relevant deals: 82
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Therapeutics

Alexandria Venture Investments is a venture capital firm that develops work in real estate technology, and healthcare sectors. The company's strategic venture capital platform is Alexandria Venture Investments. Since its inception in 1996, the company has invested in disruptive life science, agrifood tech, and technology companies that aredeveloping transformative new modalities and platforms to meaningfully improve human health.

## Versant Ventures
- Type: VC Fund
- Location: Menlo Park, California, United States
- Relevant deals: 74
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.

## Novo Holdings
- Type: VC Fund
- Location: Hellerup, Hovedstaden, Denmark
- Relevant deals: 72
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

## New Enterprise Associates
- Type: VC Fund
- Location: Menlo Park, California, United States
- Relevant deals: 71
- Stages: Series B, Series A, Series C
- Focus: Software, Health Care, Biotechnology

New Enterprise Associates, Inc. is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors, and geographies. With over $19 billion in cumulative committed capital since the firm’s founding in 1977, NEA invests in technology and healthcare companies at all stages in a company’slifecycle, from the seed stage through IPO. The firm's long track record of successful investing includes more than 210 portfolio company IPOs and more than 360 acquisitions.

## Atlas Venture
- Type: VC Fund
- Location: Cambridge, Massachusetts, United States
- Relevant deals: 66
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Therapeutics

Atlas Venture is an early-stage venture capital firm that creates and invests in biotech startup companies led by promising entrepreneurs focusing on life sciences innovation. Its seed-led venture creation strategy rigorously selects and focuses investment on compelling opportunities to build scalable businesses and realize value.

## F-Prime Capital
- Type: VC Fund
- Location: Cambridge, Massachusetts, United States
- Relevant deals: 66
- Stages: Series A, Series B, Series C
- Focus: Health Care, Biotechnology, Medical

F-Prime Capital is a global venture capital firm investing in healthcare and technology, with a heritage that spans four decades.

## MPM Capital
- Type: VC Fund
- Location: Cambridge, Massachusetts, United States
- Relevant deals: 64
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Pharmaceutical

Powering Breakthroughs in Life Sciences

## 5AM Ventures
- Type: VC Fund
- Location: Menlo Park, California, United States
- Relevant deals: 64
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Therapeutics

5AM Ventures is a venture capital firm that offers seed- and early-stage investments to its clients. The company’s client portfolio consists of firms in the biopharmaceutical, life sciences, medical technology, and research instrument industries.
5AM Ventures was founded in 2002 by John Diekman and Andrew Schwab and is based in California.

## Innova Memphis
- Type: VC Fund
- Location: Memphis, Tennessee, United States
- Relevant deals: 63
- Stages: Seed, Pre-Seed, Convertible Note
- Focus: Health Care, Medical, Medical Device

Founded in 2007 by the Memphis Bioworks Foundation, Innova is a pre-seed, seed and early-stage investor focused on starting and funding high-growth companies in the Biosciences, Technology and AgBio fields across the state of Tennessee. Innova links capital with great ideas to create groundbreaking products and services.At Innova we invest instart-up companies, help them grow, and then assist them in linking with established corporations for licensing, buy-outs or further investments. We provide the synergy of experienced management, market expertise and venture capital to accelerate the development of new products and services into viable business units that can stand on their own and then take their place with a mature market leader, if desired.Whether an innovation is still on the drawing board or stalled in the market place the Innova staff has the expertise, skills, and experience to envision and create a functioning business unit that is prepared to thrive in the market place. Technical know-how, market-proven staffing, and "just-right" funding assure the greatest chance possible for success.

## Khosla Ventures
- Type: VC Fund
- Location: Menlo Park, California, United States
- Relevant deals: 60
- Stages: Series A, Series B, Seed
- Focus: Software, Health Care, Artificial Intelligence

Khosla Ventures invests in companies that are bold, early and impactful. The firm was started in 2004 by Vinod Khosla, co-founder of Sun Microsystems, to provide venture assistance to entrepreneurs. Headquartered in Menlo Park, Calif., Khosla Ventures invests in a range of areas including AI, climate, sustainability, enterprise, consumer, fintech,digital health, medtech and diagnostics, therapeutics and frontier technology.

## Polaris Partners
- Type: VC Fund
- Location: Boston, Massachusetts, United States
- Relevant deals: 60
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Medical

Polaris Partners invests in healthcare and biotechnology companies. Their healthcare portfolio companies' care delivery models include digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics. Their life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics,and genomics.

## Novartis Venture Fund
- Type: VC Fund
- Location: Basel, Basel-Stadt, Switzerland
- Relevant deals: 57
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Therapeutics

Our primary focus is on the development of novel therapeutics and platforms. We balance the therapeutic focus with investments in medical devices, diagnostics or drug delivery systems. In our investments we look for unmet need and clinical impact, novel proprietary science and understanding of mechanism, management and board experience and capitalefficiency in the program.We prefer to have our initial investment at the early stage to build the company and follow with additional investment in pace with the company:tm:s progress. We continue our approach of larger focused investments and anticipate total investments up to USD 30 to 50 mio per company over its life, but it can be as little as 100'000 USD to get started. We will increase our activities to lead or co-lead deals further and remain open to participate in larger syndicates. SectorsNew therapeutics & platformsMedical devices/implantsDiagnostics/biomarkersDrug delivery/biopolymersGeographyUSA/CanadaEuropeSwitzerlandAsia/Pacific

## Third Rock Ventures
- Type: VC Fund
- Location: Boston, Massachusetts, United States
- Relevant deals: 55
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Therapeutics

Third Rock Ventures is a leading healthcare venture firm focused on advancing disruptive areas of science and medicine to deliver breakthroughs to patients.

## RA Capital Management
- Type: VC Fund
- Location: Boston, Massachusetts, United States
- Relevant deals: 55
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Therapeutics

RA Capital Management is an investment advisor based in Boston specializing in the life-sciences and drug development sectors. The company's team has been investing since 2002 and is comprised of professionals with training in biology, chemistry, and medicine and also has industry and business development experience at the executive and boardlevels. The company invests in companies with promising technologies and products.

## M Ventures
- Type: VC Fund
- Location: Amsterdam, Noord-Holland, The Netherlands
- Relevant deals: 54
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Health Care, Therapeutics

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

## Canaan Partners
- Type: VC Fund
- Location: Menlo Park, California, United States
- Relevant deals: 53
- Stages: Series A, Series B, Series C
- Focus: Software, Biotechnology, Health Care

Canaan is an early stage venture capital firm that invests in entrepreneurs with visionary ideas. With $5B under management, a diversified fund and over 190 exits to date, Canaan has invested in some of the world's leading technology and healthcare companies over the past 30 years. Canaan’s focus areas include fintech, enterprise/cloud,marketplaces, frontier tech, biopharma, digital health, and medtech.

## Qiming Venture Partners
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 51
- Stages: Series B, Series A, Series C
- Focus: Health Care, Medical, Biotechnology

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, Seattle, Boston and the San Francisco Bay Area.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.4 billion in capital raised. Since our establishment, we have investedin outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 480 fast-growing and innovative companies. Over 180 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange or Shenzhen Stock Exchange, or through M&A or by other means. There are also over 70 portfolio companies that have achieved unicorn status.

## Bpifrance
- Type: VC Fund
- Location: Maisons-alfort, Ile-de-France, France
- Relevant deals: 51
- Stages: Seed, Series A
- Focus: Software, Health Care, Information Technology

Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.Bpifrance was founded in 2012 and is based in Maisons-alfort, Ile-de-France,France.

## UK Innovation & Science Seed Fund
- Type: VC Fund
- Location: Harwell, Oxfordshire, United Kingdom
- Relevant deals: 51
- Stages: Seed, Series A
- Focus: Biotechnology, Health Care, Medical

UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs

## BioAdvance
- Type: VC Fund
- Location: Philadelphia, Pennsylvania, United States
- Relevant deals: 50
- Stages: Seed, Series A
- Focus: Biotechnology, Health Care, Medical

BioAdvance actively invests venture capital in therapies, medical devices, research tools, diagnostics and health IT in the Mid-Atlantic region.

## High-Tech Grunderfonds
- Type: VC Fund
- Location: Bonn, Nordrhein-Westfalen, Germany
- Relevant deals: 49
- Stages: Seed, Series A
- Focus: Software, Information Technology, Biotechnology

High-Tech Gründerfonds (HTGF) is a seed investor that finances high-potential, tech-driven startups. With EUR 895.5 million in total investment volume across three funds and an international network of partners, HTGF has already helped forge more than 500 startups since 2005. Driven by their expertise, entrepreneurial spirit, and passion, its teamof experienced investment managers and startup experts help guide the development of young companies. HTGF’s focus is on high-tech startups in a range of sectors, including software, media, internet, hardware, automation, health care, chemistry, and life sciences.To date, external investors have injected over EUR 2 billion into the HTGF portfolio via about 1,400 follow-on financing rounds. HTGF has also successfully sold interests in more than 100 companies. Investors in this public-private partnership include the Federal Ministry For Economic Affairs and Energy, the KfW Banking Group, and Fraunhofer-Gesellschaft e.V., as well as the companies ALTANA, BASF, BAYER, B.Braun, Boehringer Ingelheim, Robert Bosch, BÜFA, CEWE, Deutsche Post DHL, Dräger, Drillisch AG, EVONIK, EWE AG, FOND OF Haniel, Hettich, Knauf, Körber, LANXESS, media + more venture Beteiligungs GmbH & Co. KG, PHOENIX CONTACT, Postbank, QIAGEN, RWE Generation SE, SAP, Schufa, Schwarz Gruppe, STIHL, Thüga, Vector Informatik, WACKER and Wilh. Werhahn KG.

## Takeda Ventures
- Type: VC Fund
- Location: San Diego, California, United States
- Relevant deals: 48
- Stages: Series A, Series B
- Focus: Biotechnology, Health Care, Therapeutics

Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.

## Fifty Years
- Type: VC Fund
- Location: San Francisco, California, United States
- Relevant deals: 45
- Stages: Seed, Series A, Series B
- Focus: Biotechnology, Health Care, Medical

WE BACK HEROES   using technology to solve the world's biggest problems

## Boehringer Ingelheim Venture Fund
- Type: VC Fund
- Location: Ingelheim Am Rhein, Rheinland-Pfalz, Germany
- Relevant deals: 45
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Health Care, Therapeutics

The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.

## Sequoia Capital China
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 44
- Stages: Series A, Series B, Series C
- Focus: Health Care, Biotechnology, Artificial Intelligence

We help founders build enduring companies.

## SR One
- Type: VC Fund
- Location: Cambridge, Massachusetts, United States
- Relevant deals: 44
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Therapeutics

SR One Capital Management is a leading trans-Atlantic biotech venture capital firm that partners with top entrepreneurs, scientists and investment partners to seek to build elite biotechnology companies. Our mission is to translate ground-breaking technologies into next generation medicines to benef

## Pfizer Venture Investments
- Type: VC Fund
- Location: New York, New York, United States
- Relevant deals: 43
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Therapeutics

Pfizer Venture Investments is a corporate venture capital firm that invests in areas of current or future strategic interest to Pfizer. It aims to remain at the forefront of life science advances. It identifies and invests in emerging companies that are developing transformative medicines and technologies that have the potential to enhance Pfizer’spipeline and shape the future of its industry.

## DCVC
- Type: VC Fund
- Location: San Francisco, California, United States
- Relevant deals: 43
- Stages: Seed, Series A, Series B
- Focus: Software, Artificial Intelligence, Health Care

We are deep tech venture capital.

## Parkwalk Advisors
- Type: VC Fund
- Location: London, England, United Kingdom
- Relevant deals: 42
- Stages: Seed, Series A, Series B
- Focus: Biotechnology, Health Care, Software

Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.

## Lilly Asia Ventures
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 42
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto. 

## Casdin Capital
- Type: VC Fund
- Location: New York, New York, United States
- Relevant deals: 41
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Therapeutics

Casdin Capital is a fundamental research investment firm focused on the life sciences and healthcare industry. It manages a long-short equity fund and makes investments in early-stage to late-stage private investments. Casdin was launched in 2012 by founder and CIO Eli Casdin and as of October 2020 has approximately $2.2 billion in assets undermanagement.

## EQT life science
- Type: VC Fund
- Location: Amsterdam, Noord-Holland, The Netherlands
- Relevant deals: 41
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Therapeutics

EQT life science develops innovative medicines, devices, and tools to address the single important thing that matters to the preservation of health. The organization believes that such opportunities add value to all stakeholders.

## Seventure Partners
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 41
- Stages: Series A, Series B
- Focus: Biotechnology, Health Care, Software

Seventure Partners is a French venture capital firm targeting in information and communication technology, and life sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with€ 660 million under management as of December 31, 2016. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.

## Sofinnova Investments
- Type: VC Fund
- Location: Menlo Park, California, United States
- Relevant deals: 40
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Pharmaceutical

Sofinnova deploys human and financial capital to turn dreams into drugs. We are a clinical-stage biopharmaceutical venture capital firm with approximately $2B in assets under management and committed capital.

## Frazier Healthcare Partners
- Type: VC Fund
- Location: Seattle, Washington, United States
- Relevant deals: 40
- Stages: Series B, Series A, Post-IPO Equity
- Focus: Biotechnology, Health Care, Therapeutics

Frazier Healthcare Partners: Investing exclusively in healthcare for 25 years.

## Lux Capital
- Type: VC Fund
- Location: New York, New York, United States
- Relevant deals: 40
- Stages: Series A, Seed, Series B
- Focus: Software, Health Care, Biotechnology

Lux Capital manages over $5 billion in assets focused on founding, seed, early-stage, and growth investments at the intersection of technology and the sciences. Lux takes an active role in helping entrepreneurs build successful businesses in high-growth sectors. Its investment team has built over 20 companies from scratch. Lux's investmentstrategy ensures portfolio companies are better connected, have a deeper insight, and command industry leadership faster than their competitors.

## Andreessen Horowitz
- Type: VC Fund
- Location: Menlo Park, California, United States
- Relevant deals: 40
- Stages: Series A, Series B, Seed
- Focus: Software, Information Technology, Internet

Andreessen Horowitz (a16z) is a venture capital firm in Silicon Valley, California, investing in bold founders, innovators, and entrepreneurs building the future through technology.

## Connecticut Innovations
- Type: VC Fund
- Location: Rocky Hill, Connecticut, United States
- Relevant deals: 40
- Stages: Series A, Seed
- Focus: Health Care, Biotechnology, Software

At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.

## Hatteras Venture Partners
- Type: VC Fund
- Location: Durham, North Carolina, United States
- Relevant deals: 39
- Stages: Series A, Series B
- Focus: Biotechnology, Health Care, Medical

Hatteras Venture Partners is a venture capital firm based in Research Triangle Park, NC, with a focus on biopharmaceuticals, medical devices, diagnostics, and related opportunities in human medicine. Founded in 2000, the firm consists of an experienced team with a broad and complementary skill set that is particularly relevant to buildingsuccessful new biomedical companies. The Hatteras Venture Partners team brings operational experience, a successful track record, and a proven ability to enhance the value of the companies in which it invests. With three funds, the firm has more than $120 million under management.

## Google Ventures
- Type: VC Fund
- Location: Mountain View, California, United States
- Relevant deals: 38
- Stages: Series B, Series A, Seed
- Focus: Software, Health Care, Biotechnology

GV supports innovative founders moving the world forward.

## Northpond Ventures
- Type: VC Fund
- Location: Bethesda, Maryland, United States
- Relevant deals: 38
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Life Science

Northpond Ventures is a science-driven venture capital firm headquartered in Bethesda, Maryland. Our mission is to build a better tomorrow. Our investments are focused on life sciences, technology, and affiliated industries.

## The Column Group
- Type: VC Fund
- Location: San Francisco, California, United States
- Relevant deals: 37
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Therapeutics

The Column Group is a leading venture capital firm dedicated to creating the next generation of biotechnology companies

## Amgen Ventures
- Type: VC Fund
- Location: San Francisco, California, United States
- Relevant deals: 37
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Therapeutics

Amgen Ventures is a venture capital investment arm of Amgen Inc. specializing in investments in early and later stage companies. The firm primarily invests in the biotechnology sector with a focus on discovering and developing human therapeutics with a focus on oncology, inflammation, hematology, nephrology, metabolic disorders, neuroscience, andcardiovascular therapeutics. In oncology and hematology it focuses on novel therapeutics including signal transduction, cell cycle, and apoptosis; hematopoiesis including anemia, neutropenia, and stem cell mobilization; and supportive care including mucositis and cachexia. In nephrology the firm focuses on renal failure and hyperparathyroidism. For inflammation the firm focuses on rheumatoid arthritis, psoriasis, systemic lupus erythematosus, inflammatory bowel disease, multiple sclerosis, asthma and COPD, and osteoarthritis. Under cardiovascular, it focuses on acute coronary syndromes, dyslipidemia, and heart failure and under metabolic disorders it focuses on diabetes, metabolic syndrome, and osteoporosis. The focus on neuroscience included pain including neuropathic and inflammatory, alzheimer's disease, parkinson's disease, sleep disorder, cognition, and schizophrenia. In discovery research and technology the firm focuses on early-stage drug discovery collaborations, innovative chemical entity collections, diagnostics and biomarkers, novel antibody platforms, assay biologicals and devices, and target-focused structural biology and computational tools. It primarily invests in the North America, Europe, and the United Kingdom. The firm typically invests between $2 million and $3 million per transaction and may invest up to $10 million per company. It prefers to have an ownership stake of less than 15 % in its portfolio companies. Amgen Ventures was founded in 2004 and is based in San Francisco, California with additional offices in Seattle, Washington; Thousand Oaks, California; and Cambridge, Massachusetts.

## Scottish Investment Bank
- Type: VC Fund
- Location: Glasgow, Glasgow City, United Kingdom
- Relevant deals: 36
- Stages: Seed, Series A
- Focus: Software, Biotechnology, Information Technology

Our Entrepreneurship team (formerly the Scottish Investment Bank) helps you find sources of finance, engage with funders and secure investment to grow your business.

## Life Science Angels
- Type: VC Fund
- Location: Sunnyvale, California, United States
- Relevant deals: 36
- Stages: Seed, Series A
- Focus: Biotechnology, Health Care, Medical

Life Science Angels, Inc. (LSA) is the premier angel investment group focused solely on healthcare investing, including medical devices, diagnostics, pharmaceuticals, biotechnology, and digital health.

## Boston Harbor Angels
- Type: VC Fund
- Location: Boston, Massachusetts, United States
- Relevant deals: 36
- Stages: Angel, Seed, Series A
- Focus: Biotechnology, Health Care, Medical Device

Boston Harbor Angels is a group of proven business leaders interested in investing a portion of their assets in high growth, early stage companies. The group was formed in February 2004 and since then has made a number of investments in companies in medical devices, IT, consumer products, business products, specialty materials, Internet, aviation,etc. They believe they contribute more than money to the companies they fund and welcome the opportunity to work with entrepreneurs open to take advice, yet having the smarts and determination to make the company successful.Their focus is on early stage companies usually looking to raise $250K to $1.5M, where they can fund a portion of the round and syndicate the deal with other angel groups or early stage venture funds. The stage of the company should be close to commercialization, while the company should have a clear and defensible competitive advantage. They are looking for capital efficient businesses, which can reach profitability with less than $5M of equity investment and provide at least 10X return on the investment within 5 years.They do not invest as a fund - each of their members makes his or her individual investment decision but they collaborate in Due Diligence. They have a deep expertise in the life sciences field where they usually take the position of a lead investor, but are open to any opportunities that can make a strong business case. In some cases they prefer to be the follow on investor if they cannot identify a person with strong expertise within their group.The group’s strategy is directed by an executive committee which consists of 8 people elected by the group: Wayne Griffith (chairman), Bill McPhee, Henry Kay, Jay Schwartz (membership director), Steve Andress, Peter Miller, Don Freeman and Mic Williams (president and founder). The group’s day-to-day operations are managed by Boris Batchvarov (managing director).They receive 20-30 business summaries each month, out of which they select 8 companies to make a personal presentation to their screening committee. The screening committee consists of volunteers from the group. The presentations are 10 min long followed by 10 min Q&A. 4 of the companies are invited to present to the whole group, with the idea to get the people interested and decide to perform a Due Diligence with the companies before making an investment.

## HealthCap
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 36
- Stages: Series B, Series A
- Focus: Biotechnology, Health Care, Medical

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co